-
Medical journals
- Career
Immune-deficient mouse asa model for the study of leukaemias
Authors: M. Doubek 1; K. Řeháková 2; P. Scheer 2; J. Doubek 2; J. Mayer 1
Authors‘ workplace: Interní hematoonkologická klinika Lékařské fakulty Masarykovy univerzity a FN Brno, 2Ústav fyziologie a patofyziologie Fakulty veterinárního lékařství Veterinární a farmaceutické univerzity, Brno 1
Published in: Transfuze Hematol. dnes,, 2004, No. 4, p. 149-153.
Category:
Overview
Experimental models of human leukaemias are used in attempts to reconstruct events that occur inpatients with this cancer. Although in vitro systems provide a wealth of information about the cellularand molecular biology of leukaemic cells, they are inadequate for studies that address the complexitiesof human leukaemia and experimental treatment of this disease. Since the late 1960s, athymic nudemice have provided an opportunity to study xenografted human leukaemia in vivo. Recently, thesuccessful engraftment of human haematopoietic cells into various immune-deficient mice offers anapproach to study human haematopoiesis and leukaemia. The goals of this review are to discuss howmouse models have been utilized to study human leukaemia, and to provide an assessment of thestrengths and limitations of mouse models.
Key words:
immune-deficient mouse, leukaemia, SCID mouse, xenograft
Labels
Haematology Internal medicine Clinical oncology
Article was published inTransfusion and Haematology Today
2004 Issue 4-
All articles in this issue
- Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoringin children with acute lymphoblastic leukaemia?
- Chronic lymphocytic leukemia: mutationalstatus of the immunoglobulin heavy chain gene is a significant prognostic marker
- Immune-deficient mouse asa model for the study of leukaemias
- Anagrelide in the treatment of essential thrombocythemia
- Overview of conservative treatment of myelodysplastic syndrom overthe twenty years and new drugs for the future
- Transfusion and Haematology Today
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoringin children with acute lymphoblastic leukaemia?
- Anagrelide in the treatment of essential thrombocythemia
- Chronic lymphocytic leukemia: mutationalstatus of the immunoglobulin heavy chain gene is a significant prognostic marker
- Immune-deficient mouse asa model for the study of leukaemias
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career